$3.55 Billion is the total value of Eventide Asset Management's 116 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 40.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A Ssponsored adr | $236,316,000 | +44.4% | 1,698,648 | 0.0% | 6.66% | +23.2% | |
| ZGNX | ZOGENIX INC | $148,117,000 | +30.2% | 2,841,300 | 0.0% | 4.17% | +11.0% | |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $128,524,000 | +40.0% | 996,000 | -18.3% | 3.62% | +19.3% |
| TTD | THE TRADE DESK INC | $110,407,000 | +38.5% | 425,000 | 0.0% | 3.11% | +18.1% | |
| AIMT | AIMMUNE THERAPEUTICS INC | $103,221,000 | +59.8% | 3,084,000 | 0.0% | 2.91% | +36.3% | |
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $88,955,000 | +30.5% | 1,634,000 | 0.0% | 2.51% | +11.3% | |
| FIVN | FIVE9 INC | $81,975,000 | +22.0% | 1,250,000 | 0.0% | 2.31% | +4.1% | |
| TWLO | TWILIO INCcl a | $81,278,000 | -10.6% | 827,000 | 0.0% | 2.29% | -23.8% | |
| ROP | ROPER TECHNOLOGIES INC | $75,805,000 | -0.7% | 214,000 | 0.0% | 2.14% | -15.3% | |
| WCN | WASTE CONNECTIONS INC | $72,995,000 | -1.3% | 804,000 | 0.0% | 2.06% | -15.8% | |
| LOW | Buy | LOWES COS INC | $70,706,000 | +10.5% | 590,400 | +1.5% | 1.99% | -5.8% |
| PANW | PALO ALTO NETWORKS INC | $66,369,000 | +13.5% | 287,000 | 0.0% | 1.87% | -3.3% | |
| SPLK | SPLUNK INC | $64,102,000 | +27.1% | 428,000 | 0.0% | 1.81% | +8.3% | |
| MYOV | Sell | MYOVANT SCIENCES LTD | $64,038,000 | +162.3% | 4,126,131 | -12.1% | 1.80% | +123.5% |
| XYL | Buy | XYLEM INC | $62,228,000 | -0.7% | 789,800 | +0.3% | 1.75% | -15.4% |
| LRCX | Sell | LAM RESEARCH CORP | $58,772,000 | +12.0% | 201,000 | -11.5% | 1.66% | -4.4% |
| MTD | METTLER TOLEDO INTERNATIONAL | $57,600,000 | +12.6% | 72,610 | 0.0% | 1.62% | -4.0% | |
| SAGE | SAGE THERAPEUTICS INC | $57,030,000 | -48.5% | 790,000 | 0.0% | 1.61% | -56.1% | |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $56,121,000 | -0.2% | 1,065,922 | +0.2% | 1.58% | -14.9% |
| HUBS | HUBSPOT INC | $55,475,000 | +4.5% | 350,000 | 0.0% | 1.56% | -10.8% | |
| ASML | Buy | ASML HOLDING N V | $53,536,000 | +20.8% | 180,900 | +1.4% | 1.51% | +3.0% |
| W | WAYFAIR INCcl a | $51,782,000 | -19.4% | 573,000 | 0.0% | 1.46% | -31.3% | |
| MGTA | Buy | MAGENTA THERAPEUTICS INC | $51,451,000 | +69.7% | 3,393,894 | +14.8% | 1.45% | +44.7% |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $49,968,000 | +79.3% | 2,427,976 | 0.0% | 1.41% | +52.9% | |
| LII | LENNOX INTL INC | $48,794,000 | +0.4% | 200,000 | 0.0% | 1.38% | -14.4% | |
| ARGX | Buy | ARGENX SEsponsored adr | $47,723,000 | +82.1% | 297,300 | +29.3% | 1.34% | +55.3% |
| VMC | Buy | VULCAN MATLS CO | $45,918,000 | -4.3% | 318,900 | +0.5% | 1.29% | -18.4% |
| CCI | Buy | CROWN CASTLE INTL CORP NEW | $45,929,000 | +3.7% | 323,100 | +1.4% | 1.29% | -11.6% |
| EXAS | EXACT SCIENCES CORP | $45,778,000 | +2.3% | 495,000 | 0.0% | 1.29% | -12.7% | |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $45,588,000 | +126.5% | 436,000 | +149.1% | 1.28% | +93.2% |
| MYOK | MYOKARDIA INC | $45,262,000 | +39.8% | 621,000 | 0.0% | 1.28% | +19.2% | |
| STML | STEMLINE THERAPEUTICS INC | $44,227,000 | +2.1% | 4,160,608 | 0.0% | 1.25% | -12.9% | |
| SMAR | SMARTSHEET INC | $43,797,000 | +24.7% | 975,000 | 0.0% | 1.23% | +6.3% | |
| BEP | Buy | BROOKFIELD RENEWABLE PARTNERpartnership unit | $42,536,000 | +1148.1% | 912,200 | +987.2% | 1.20% | +961.1% |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $42,527,000 | +63.8% | 535,000 | 0.0% | 1.20% | +39.6% | |
| POOL | POOL CORPORATION | $39,290,000 | +5.3% | 185,000 | 0.0% | 1.11% | -10.2% | |
| MRTX | MIRATI THERAPEUTICS INC | $38,787,000 | +65.4% | 301,000 | 0.0% | 1.09% | +41.0% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $37,944,000 | +19.3% | 353,000 | 0.0% | 1.07% | +1.7% | |
| BPMC | BLUEPRINT MEDICINES CORP | $37,011,000 | +9.0% | 462,000 | 0.0% | 1.04% | -7.0% | |
| QURE | UNIQURE NV | $35,830,000 | +82.1% | 500,000 | 0.0% | 1.01% | +55.4% | |
| IPHI | Sell | INPHI CORP | $33,309,000 | -1.7% | 450,000 | -18.9% | 0.94% | -16.2% |
| VRNS | VARONIS SYS INC | $32,638,000 | +30.0% | 420,000 | 0.0% | 0.92% | +10.8% | |
| MGA | MAGNA INTL INC | $32,191,000 | +2.8% | 587,000 | 0.0% | 0.91% | -12.3% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $32,205,000 | +95.4% | 1,415,000 | 0.0% | 0.91% | +66.4% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $29,921,000 | +53.5% | 1,680,000 | 0.0% | 0.84% | +30.9% | |
| CTAS | CINTAS CORP | $29,868,000 | +0.4% | 111,000 | 0.0% | 0.84% | -14.3% | |
| IAA | IAA INC | $28,707,000 | +12.8% | 610,000 | 0.0% | 0.81% | -3.8% | |
| TREX | New | TREX CO INC | $26,874,000 | – | 299,000 | +100.0% | 0.76% | – |
| IDXX | IDEXX LABS INC | $26,870,000 | -4.0% | 102,900 | 0.0% | 0.76% | -18.2% | |
| ODFL | Buy | OLD DOMINION FREIGHT LINE IN | $26,645,000 | +16.1% | 140,400 | +4.0% | 0.75% | -0.9% |
| PAYC | Sell | PAYCOM SOFTWARE INC | $26,476,000 | -10.4% | 100,000 | -29.1% | 0.75% | -23.6% |
| AVRO | AVROBIO INC | $26,276,000 | +42.6% | 1,305,307 | 0.0% | 0.74% | +21.5% | |
| VCYT | VERACYTE INC | $25,966,000 | +16.3% | 930,000 | 0.0% | 0.73% | -0.7% | |
| APTV | Sell | APTIV PLC | $25,518,000 | +2.1% | 268,700 | -6.0% | 0.72% | -13.0% |
| LEA | LEAR CORP | $25,245,000 | +16.4% | 184,000 | 0.0% | 0.71% | -0.8% | |
| NOVT | New | NOVANTA INC | $24,763,000 | – | 280,000 | +100.0% | 0.70% | – |
| HASI | Buy | HANNON ARMSTRONG SUST INFR C | $24,505,000 | +18.4% | 761,500 | +7.3% | 0.69% | +0.9% |
| MNTA | MOMENTA PHARMACEUTICALS INC | $24,386,000 | +52.2% | 1,236,000 | 0.0% | 0.69% | +29.9% | |
| CRNX | CRINETICS PHARMACEUTICALS IN | $23,760,000 | +66.8% | 947,000 | 0.0% | 0.67% | +42.0% | |
| AY | Buy | ATLANTICA YIELD PLC | $20,969,000 | +10.7% | 794,600 | +1.0% | 0.59% | -5.6% |
| DT | New | DYNATRACE INC | $20,870,000 | – | 824,900 | +100.0% | 0.59% | – |
| ESTC | Buy | ELASTIC N V | $20,576,000 | +66.6% | 320,000 | +113.3% | 0.58% | +42.2% |
| PFPT | PROOFPOINT INC | $18,135,000 | -11.1% | 158,000 | 0.0% | 0.51% | -24.2% | |
| XPO | XPO LOGISTICS INC | $17,534,000 | +11.4% | 220,000 | 0.0% | 0.49% | -5.0% | |
| IMVTU | New | IMMUNOVANT INCunit 12/18/2024 added | $16,912,000 | – | 680,000 | +100.0% | 0.48% | – |
| XENE | XENON PHARMACEUTICALS INC | $16,703,000 | +45.5% | 1,274,100 | 0.0% | 0.47% | +24.3% | |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $16,186,000 | +235.0% | 214,843 | -27.4% | 0.46% | +185.0% |
| ISRG | INTUITIVE SURGICAL INC | $14,779,000 | +9.5% | 25,000 | 0.0% | 0.42% | -6.7% | |
| PHAT | New | PHATHOM PHARMACEUTICALS INC | $14,013,000 | – | 450,000 | +100.0% | 0.40% | – |
| STRO | Buy | SUTRO BIOPHARMA INC | $13,694,000 | +187.0% | 1,244,895 | +137.1% | 0.39% | +144.3% |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $12,392,000 | – | 100,000 | +100.0% | 0.35% | – |
| MDB | MONGODB INCcl a | $12,174,000 | +9.2% | 92,500 | 0.0% | 0.34% | -6.8% | |
| EXR | EXTRA SPACE STORAGE INC | $11,618,000 | -9.6% | 110,000 | 0.0% | 0.33% | -23.1% | |
| OKTA | Sell | OKTA INCcl a | $11,537,000 | -21.9% | 100,000 | -33.3% | 0.32% | -33.4% |
| DDOG | DATADOG INC | $11,334,000 | +11.4% | 300,000 | 0.0% | 0.32% | -5.1% | |
| RGEN | REPLIGEN CORP | $11,008,000 | +20.6% | 119,000 | 0.0% | 0.31% | +2.6% | |
| GLPG | Sell | GALAPAGOS NVspon adr | $10,548,000 | -60.1% | 51,000 | -70.5% | 0.30% | -66.0% |
| EPIX | ESSA PHARMA INC | $10,503,000 | +63.2% | 2,010,169 | 0.0% | 0.30% | +39.0% | |
| XNCR | XENCOR INC | $10,317,000 | +2.0% | 300,000 | 0.0% | 0.29% | -12.9% | |
| ETNB | New | 89BIO INC | $9,202,000 | – | 350,000 | +100.0% | 0.26% | – |
| ARYAU | ARYA SCIENCES ACQUISITION COunit 10/04/2023 | $9,200,000 | +4.9% | 800,000 | 0.0% | 0.26% | -10.7% | |
| STSA | SATSUMA PHARMACEUTICALS INC | $8,364,000 | +31.1% | 425,000 | 0.0% | 0.24% | +11.8% | |
| FENC | FENNEC PHARMACEUTICALS INC | $4,666,000 | +34.7% | 720,000 | 0.0% | 0.13% | +14.9% | |
| ETTX | Buy | ENTASIS THERAPEUTICS HLDGS I | $4,300,000 | +87.9% | 879,541 | +124.1% | 0.12% | +59.2% |
| ARE | Buy | ALEXANDRIA REAL ESTATE EQ IN | $3,943,000 | +38.4% | 24,400 | +31.9% | 0.11% | +18.1% |
| ORTX | ORCHARD THERAPEUTICS PLCads | $3,713,000 | +15.7% | 270,000 | 0.0% | 0.10% | -0.9% | |
| PLD | Buy | PROLOGIS INC | $3,289,000 | +58.8% | 36,900 | +51.9% | 0.09% | +36.8% |
| FHN | Buy | FIRST HORIZON NATL CORP | $3,267,000 | +88.6% | 197,300 | +84.6% | 0.09% | +61.4% |
| NEE | Buy | NEXTERA ENERGY INC | $3,197,000 | +16.3% | 13,200 | +11.9% | 0.09% | -1.1% |
| OKE | Buy | ONEOK INC NEW | $3,087,000 | +33.0% | 40,800 | +29.5% | 0.09% | +13.0% |
| CMS | New | CMS ENERGY CORP | $2,953,000 | – | 47,000 | +100.0% | 0.08% | – |
| A | Buy | AGILENT TECHNOLOGIES INC | $2,790,000 | +86.7% | 32,700 | +67.7% | 0.08% | +61.2% |
| EQIX | Buy | EQUINIX INC | $2,685,000 | +22.5% | 4,600 | +21.1% | 0.08% | +5.6% |
| LW | Buy | LAMB WESTON HLDGS INC | $2,710,000 | +372.1% | 31,500 | +298.7% | 0.08% | +300.0% |
| FRC | Buy | FIRST REP BK SAN FRANCISCO C | $2,549,000 | +48.9% | 21,700 | +22.6% | 0.07% | +26.3% |
| WM | Buy | WASTE MGMT INC DEL | $2,427,000 | +8.2% | 21,300 | +9.2% | 0.07% | -8.1% |
| BXP | New | BOSTON PROPERTIES INC | $2,413,000 | – | 17,500 | +100.0% | 0.07% | – |
| IR | Buy | INGERSOLL-RAND PLC | $2,313,000 | +19.6% | 17,400 | +10.8% | 0.06% | +1.6% |
| Buy | PALO ALTO NETWORKS INCnote 0.750% 7/0 | $2,089,000 | +23.6% | 1,890,000 | +18.1% | 0.06% | +5.4% | |
| Buy | NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $1,997,000 | +45.6% | 1,300,000 | +30.0% | 0.06% | +24.4% | |
| JCI | Buy | JOHNSON CTLS INTL PLC | $1,946,000 | +50.3% | 47,800 | +62.0% | 0.06% | +27.9% |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $1,676,000 | – | 11,200 | +100.0% | 0.05% | – |
| IEX | Buy | IDEX CORP | $1,582,000 | +48.5% | 9,200 | +41.5% | 0.04% | +28.6% |
| ZTS | New | ZOETIS INCcl a | $1,324,000 | – | 10,000 | +100.0% | 0.04% | – |
| DHI | New | D R HORTON INC | $1,113,000 | – | 21,100 | +100.0% | 0.03% | – |
| KLAC | New | KLA CORPORATION | $1,016,000 | – | 5,700 | +100.0% | 0.03% | – |
| New | INTERCEPT PHARMACEUTICALS INnote 2.000% 5/1 | $981,000 | – | 736,000 | +100.0% | 0.03% | – | |
| New | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $941,000 | – | 483,000 | +100.0% | 0.03% | – | |
| BWA | New | BORGWARNER INC | $963,000 | – | 22,200 | +100.0% | 0.03% | – |
| FNB | New | FNB CORP PA | $975,000 | – | 76,800 | +100.0% | 0.03% | – |
| New | INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $829,000 | – | 820,000 | +100.0% | 0.02% | – | |
| TER | New | TERADYNE INC | $743,000 | – | 10,900 | +100.0% | 0.02% | – |
| INFO | New | IHS MARKIT LTD | $708,000 | – | 9,400 | +100.0% | 0.02% | – |
| SIVB | New | SVB FINL GROUP | $577,000 | – | 2,300 | +100.0% | 0.02% | – |
| CCIPRA | CROWN CASTLE INTL CORP NEW6.875% con pfd a | $410,000 | +1.5% | 320 | 0.0% | 0.01% | -7.7% | |
| MLHR | Sell | MILLER HERMAN INC | $383,000 | -61.0% | 9,200 | -56.8% | 0.01% | -65.6% |
| WELL | Exit | WELLTOWER INC | $0 | – | -1,900 | -100.0% | -0.01% | – |
| ETN | Exit | EATON CORP PLC | $0 | – | -2,100 | -100.0% | -0.01% | – |
| GPMT | Exit | GRANITE PT MTG TR INC | $0 | – | -9,000 | -100.0% | -0.01% | – |
| ERIC | Exit | ERICSSONadr b sek 10 | $0 | – | -24,100 | -100.0% | -0.01% | – |
| TSM | Exit | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $0 | – | -4,800 | -100.0% | -0.01% | – |
| HMC | Exit | HONDA MOTOR LTD | $0 | – | -9,100 | -100.0% | -0.01% | – |
| ABB | Exit | ABB LTDsponsored adr | $0 | – | -16,000 | -100.0% | -0.01% | – |
| EQR | Exit | EQUITY RESIDENTIALsh ben int | $0 | – | -4,100 | -100.0% | -0.01% | – |
| Exit | MEDICINES COnote 2.750% 7/1 | $0 | – | -400,000 | -100.0% | -0.02% | – | |
| ESS | Exit | ESSEX PPTY TR INC | $0 | – | -1,800 | -100.0% | -0.02% | – |
| NVDA | Exit | NVIDIA CORP | $0 | – | -3,700 | -100.0% | -0.02% | – |
| NOK | Exit | NOKIA CORPsponsored adr | $0 | – | -288,800 | -100.0% | -0.05% | – |
| WMB | Exit | WILLIAMS COS INC DEL | $0 | – | -62,700 | -100.0% | -0.05% | – |
| NXPI | Exit | NXP SEMICONDUCTORS N V | $0 | – | -14,500 | -100.0% | -0.05% | – |
| VTR | Exit | VENTAS INC | $0 | – | -23,400 | -100.0% | -0.06% | – |
| TERP | Exit | TERRAFORM PWR INC | $0 | – | -92,800 | -100.0% | -0.06% | – |
| CBIO | Exit | CATALYST BIOSCIENCES INC | $0 | – | -462,852 | -100.0% | -0.08% | – |
| HCP | Exit | HCP INC | $0 | – | -74,200 | -100.0% | -0.09% | – |
| THOR | Exit | SYNTHORX INC | $0 | – | -400,000 | -100.0% | -0.22% | – |
| HSACU | Exit | HEALTH SCIENCES ACQUSTN CORPunit 04/01/2024 | $0 | – | -680,000 | -100.0% | -0.24% | – |
| STKL | Exit | SUNOPTA INC | $0 | – | -4,132,375 | -100.0% | -0.25% | – |
| INST | Exit | INSTRUCTURE INC | $0 | – | -330,000 | -100.0% | -0.42% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -499,000 | -100.0% | -0.46% | – |
| KAR | Exit | KAR AUCTION SVCS INC | $0 | – | -610,000 | -100.0% | -0.50% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -1,950,000 | -100.0% | -0.52% | – |
| RARX | Exit | RA PHARMACEUTICALS INC | $0 | – | -743,000 | -100.0% | -0.58% | – |
| ANET | Exit | ARISTA NETWORKS INC | $0 | – | -117,000 | -100.0% | -0.92% | – |
| PEGI | Exit | PATTERN ENERGY GROUP INCcl a | $0 | – | -1,073,200 | -100.0% | -0.96% | – |
| SERV | Exit | SERVICEMASTER GLOBAL HLDGS I | $0 | – | -750,000 | -100.0% | -1.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-01-29
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 43 | Q2 2024 | 3.2% |
| PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
| ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
| REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
| VERACYTE INC | 41 | Q2 2024 | 1.5% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
| COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
| BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
| Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
| Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
| Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
| Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
| MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
| Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
| Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-13 |
| SC 13G/A | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.